THE PERVASIVELY REGULATED BUSINESS EXCEPTION AND THE FDA

DSpace/Manakin Repository

THE PERVASIVELY REGULATED BUSINESS EXCEPTION AND THE FDA

Show simple item record

dc.contributor.advisor Hutt, Peter Barton en_US
dc.contributor.author Wood, Valerie D. en_US
dc.date.accessioned 2012-06-15T20:17:40Z
dc.date.issued 1995 en_US
dc.identifier.citation THE PERVASIVELY REGULATED BUSINESS EXCEPTION AND THE FDA (1995 Third Year Paper) en
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8889438
dc.description.abstract Section 704 of the Federal Food, Drug and Cosmetic Act authorizes the Food and Drug Administration to conduct inspections of regulated business establishments. In the statute. Congress required that the inspections be at reasonable times and within reasonable limits and in a reasonable manner. Congress further restricted the inspections from including general financial and personnel data, and research data not relating to specially regulated drugs. en
dc.language.iso en_US en
dash.license LAA en_US
dc.subject Food and Drug Law en
dc.subject warrant en
dc.subject search and seizure en
dc.subject drug regulation en
dc.title THE PERVASIVELY REGULATED BUSINESS EXCEPTION AND THE FDA en
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-06-15T20:17:40Z

Files in this item

Files Size Format View
vwood2.pdf 173.0Kb PDF View/Open
vwood2.rtf 42.95Kb RTF file View/Open
vwood2.html 47.11Kb HTML View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters